EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Competitive Endogenous RNA Network Involving Immune Subgroups, Infiltration, and lncRNAs in Prostate Cancer

Wenkang Niu iD, Tingting Zhang, Lei Ma

Genes · 2025

DOI: 10.3390/genes16050527 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Wenkang Niu und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science, Shihezi University, Shihezi 832000, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Prostatic Neoplasms, Gene Regulatory Networks. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) is the most frequently diagnosed malignancy in the male genitourinary tract. However, the regulatory mechanism of competitive endogenous RNAs (ceRNAs) in PCa remains unclear. In this study, we first performed immune scores of mRNA data from 481 PCa samples using single-sample Gene Set Enrichment Analysis (ssGSEA). Based on the immune scores, we then evaluated the tumor immune microenvironment and analyzed 28 types of immune cells in PCa, we constructed a comprehensive network with four lncRNAs (MEG3, PCAT1, SNHG19, TRG-AS1), three miRNAs (hsa-miR-488-3p, hsa-miR-210-5p, hsa-miR-137), and twenty-seven mRNAs (including H2AFJ, THBS1, HPGD). Among the 28 immune cell types, seven immune cell types were found to be significantly associated with clinical characteristics. These network nodes have prognostic significance in multiple cancers and play critical roles in malignancy development, indicating the network’s predictive capability. We also observed a strong correlation (r = 0.6) between T-helper type 1 (Th1) cells and lncRNA network modules. The network connectivity highlights the association between immune therapy biomarkers for PCa, particularly those related to H2AFJ, THBS1, and HPGD. These findings provide valuable insights into the ceRNA regulatory network and its implications for immune-based therapies in PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingProstatic NeoplasmsGene Regulatory NetworksHumansMaleGene Expression Regulation, NeoplasticTumor MicroenvironmentBiomarkers, TumorMicroRNAsRNA, MessengerPrognosisRNA, Competitive Endogenous

Stichwörter der Autor:innen

WGCNAceRNAimmune infiltrationprostate cancerssGSEA

Substanzen

RNA, Long NoncodingBiomarkers, TumorMicroRNAsRNA, MessengerRNA, Competitive Endogenous

Autor:innen und Institutionen

  • College of Life Science, Shihezi University, Shihezi 832000, China.
  • Key Laboratory of Oasis Town and Mountain-Basin System Ecology of Bingtuan, Shihezi University, Shihezi 832000, China.

ORCID-Profile: Wenkang Niu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Niu, W., Zhang, T., & Ma, L. (2025). Competitive Endogenous RNA Network Involving Immune Subgroups, Infiltration, and lncRNAs in Prostate Cancer. Genes. https://doi.org/10.3390/genes16050527

Vancouver

Niu W, Zhang T, Ma L. Competitive Endogenous RNA Network Involving Immune Subgroups, Infiltration, and lncRNAs in Prostate Cancer. Genes. 2025. doi:10.3390/genes16050527

BibTeX
@article{Niu2025,
  author = {Niu, Wenkang and Zhang, Tingting and Ma, Lei},
  title = {Competitive Endogenous RNA Network Involving Immune Subgroups, Infiltration, and lncRNAs in Prostate Cancer},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16050527}
}
Kostenlos starten →